WO2009054150A1 - テトラピロール誘導体およびその医薬用途 - Google Patents
テトラピロール誘導体およびその医薬用途 Download PDFInfo
- Publication number
- WO2009054150A1 WO2009054150A1 PCT/JP2008/003044 JP2008003044W WO2009054150A1 WO 2009054150 A1 WO2009054150 A1 WO 2009054150A1 JP 2008003044 W JP2008003044 W JP 2008003044W WO 2009054150 A1 WO2009054150 A1 WO 2009054150A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medical purposes
- tetrapyrrole derivative
- preventing
- agent
- diabetic neuropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【課題】 降圧作用や高カリウム血症を生じさせない糖尿病性腎症抑制剤を提供すること。
【解決手段】 一般式（Ｉ）で表されるテトラピロール誘導体又はその薬学的に許容された塩又はそのエステルを有効成分とする糖尿病性腎症抑制剤。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37007P | 2007-10-25 | 2007-10-25 | |
| US61/000,370 | 2007-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009054150A1 true WO2009054150A1 (ja) | 2009-04-30 |
Family
ID=40579258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2008/003044 Ceased WO2009054150A1 (ja) | 2007-10-25 | 2008-10-27 | テトラピロール誘導体およびその医薬用途 |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2009054150A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014043647A1 (en) * | 2012-09-14 | 2014-03-20 | Utah State University | Therapeutic compositions and associated methods |
| US8980616B2 (en) | 2009-11-04 | 2015-03-17 | Utah State University | Recombinant non-animal cell for making biliverdin |
| WO2020247665A1 (en) | 2019-06-05 | 2020-12-10 | Emory University | Peptidomimetics for the treatment of coronavirus and picornavirus infections |
-
2008
- 2008-10-27 WO PCT/JP2008/003044 patent/WO2009054150A1/ja not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| MASAKAZU FUJII: "Biliverdin no Tonyobyo Jinsho Kaizen Koka to sono Bunshi Kijo no Kento", TONYOBYO GAPPEISHO, vol. 21, no. SUPPL., 30 September 2007 (2007-09-30), pages 65 * |
| SHUJI SASAKI: "Taishitsusei Odan Gunn Rat ni Okeru Tonyobyo Jinsho Yokusei Koka to sono Kijo no Kento", TONYOBYO GAPPEISHO, vol. 21, no. SUPPL., 30 September 2007 (2007-09-30), pages 65 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980616B2 (en) | 2009-11-04 | 2015-03-17 | Utah State University | Recombinant non-animal cell for making biliverdin |
| US9657321B2 (en) | 2009-11-04 | 2017-05-23 | Utah State University | Recombinant non-animal cell for making biliverdin |
| WO2014043647A1 (en) * | 2012-09-14 | 2014-03-20 | Utah State University | Therapeutic compositions and associated methods |
| US9119842B2 (en) | 2012-09-14 | 2015-09-01 | Utah State University | Therapeutic meso-biliverdin IXα compositions and associated methods |
| WO2020247665A1 (en) | 2019-06-05 | 2020-12-10 | Emory University | Peptidomimetics for the treatment of coronavirus and picornavirus infections |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009054479A1 (ja) | スピロ環化合物及びその医薬用途 | |
| WO2012019426A8 (zh) | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 | |
| WO2010122980A8 (ja) | 新規甲状腺ホルモンβ受容体作動薬 | |
| WO2007117465A3 (en) | Indazole compounds | |
| WO2009017837A3 (en) | Sublingual fentanyl spray | |
| WO2008010921A3 (en) | Modulators of pharmacokinetic properties of therapeutics | |
| WO2007087431A3 (en) | Sublingual fentanyl spray | |
| WO2011012816A3 (fr) | Formulation pharmaceutique | |
| WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
| WO2012019430A8 (zh) | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| WO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| MX2009003081A (es) | Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas. | |
| WO2010128050A3 (en) | Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds | |
| WO2009041663A1 (ja) | 皮膚疾患の予防及び／または治療剤 | |
| WO2008008718A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
| EP2196206B8 (en) | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient | |
| WO2008008660A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
| WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| WO2009055289A3 (en) | Therapeutic substituted lactams | |
| WO2009038412A3 (en) | Beta-secretase inhibiting compounds | |
| WO2008021804A3 (en) | Therapeutic amides and related compounds | |
| WO2008093838A1 (ja) | スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用 | |
| WO2007146856A3 (en) | Substituted gamma lactams as therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08840876 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08840876 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |